Analysis on mechanism of severe allergic reaction caused by SNP in interleukin 13 using NMR

NMR分析白细胞介素13中SNP引起严重过敏反应的机制

基本信息

  • 批准号:
    14572032
  • 负责人:
  • 金额:
    $ 2.24万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2002
  • 资助国家:
    日本
  • 起止时间:
    2002 至 2003
  • 项目状态:
    已结题

项目摘要

We consbucted tcansibm is that express (His)_6-D-D-D-D-K fused human intedeukin 13 (Fusion IL-13) and (His)_6-D-D-D-D-K fused human mutant interieukin 13 whemArgl 10 is mutated to Gln (Fusion mutant IL-13). These bansfonnants were arlturod in M9 minimal media containing ^<15>NH_4Cl. After incubation, we got Fusion IL-13 and Fusion mutant IL-13 as inclusion bodies. Individual precipitates were dissolved in Tris-HCl buffer at pH 8 containing 6M guanidine hydrochloride. Each solution was adsorbed to Ni-NTA column and eluted with a buffer containing 50mM sodium phosphate buffer at pH 4.5 containing 6M guanidine hydrochloride. Then, the pH of the collected factions were adjusted to 8 and the solutions were reduced by 50 mM m hnol for 30min at 40 degrees. Each solution was diluted into 50 mM Tris-HCl buffer at pH 8.5 containing 3M urea, 30% glycerol, 5 mM cystamine and 5 mM cysteine and stirred for 3days at 4 degrees. After any precipitated proteins were removed by centrifugation, each sugar … More nt was applied to Ni-NTA column. After washing by 20 mM phosphate buflr at pH6.1 containing 10% glycerol, the soluble proteins were eluted with the same buffer containing 250 mM imidazole. After dialysis against 20 mM sodium phosphate buffer at pH 6.1 containing 10% glycerol, (His)_6-D-D-D-D-K in Fusion IL-13 and Fusion mutant IL-13 was processed with enterokinase by incubation for 14 hours at 20 degrees. Each reaction mixtwe was applied to cation exchange column of CM-Toyopearl 650 M. The wild-Type IL-13 and mutant IL-13 were eluted with 20 mM sodium phosphate buffer at pH 6.1 containing 1 M NaCl. We confirmed by analysis of their ^1H-^<15>N HSQC spectra that both IL-13 had correct conformations. Then, we measured T1, T2 and ^1H-^<15>N NOE with or without saturation. We evaluated order parameters and Rex values at individual residues in the wild-type IL-13 and the mutant IL-13 by means of model free analysis using above parameters (T1, T2 and NOE). Compared order parameters and Rex values at residues in the mutant IL-13 with those in the wild-type IL-13, there was difference at D-helix IL-13 between them. It was reported by mutation analysis that D-helix in IL-13 interacted with interleukin 13 receptor alpha 2. Therefore, it was suggested that the subtle weaker affinity of the mutant IL-13 than that of the wild-type IL-13 with with interleukin 13 receptor- alpha may depend on the difference in internal motions at D-helix in IL-13. Less
我们构建了表达(His)_6-D-D-D-D-K融合人白细胞介素13(Fusion IL-13)和(His)_6-D-D-D-D-K融合人突变型白细胞介素13(Fusion mutant IL-13)的表达载体。在含NH_4Cl的M_9基本培养基中,这些班氏杆菌<15>都能生长。孵育后,我们得到融合IL-13和融合突变体IL-13作为包涵体。将单个沉淀物溶解在含有6 M盐酸胍的pH 8的Tris-HCl缓冲液中。将每种溶液吸附到Ni-NTA柱上,并用含有6 M盐酸胍的pH 4.5的含有50 mM磷酸钠缓冲液的缓冲液洗脱。然后,将收集的部分的pH调节至8,并将溶液在40度下用50 mM甲醇还原30分钟。将每种溶液稀释到含有3 M尿素、30%甘油、5 mM胱胺和5 mM半胱氨酸的pH 8.5的50 mM Tris-HCl缓冲液中,并在4度下搅拌3天。在通过离心除去任何沉淀的蛋白质后, ...更多信息 NT上样于Ni-NTA柱。用含有10%甘油的pH6.1的20 mM磷酸缓冲液洗涤后,用含有250 mM咪唑的相同缓冲液洗脱可溶性蛋白质。在用含有10%甘油的pH 6.1的20 mM磷酸钠缓冲液透析后,通过在20 ℃孵育14小时,用肠激酶处理融合IL-13和融合突变体IL-13中的(His)_6-D-D-D-D-K。将各反应混合物上样到CM-Toyopolymer 650 M阳离子交换柱上。野生型IL-13和突变型IL-13用含有1 M NaCl的pH 6.1的20 mM磷酸钠缓冲液洗脱。我们通过分析它们的^1H-^<15>N HSQC光谱证实,两种IL-13都具有正确的构象。然后,我们测量了T1,T2和^1H-^<15>N NOE(有或无饱和)。我们通过使用上述参数(T1、T2和NOE)的无模型分析评估了野生型IL-13和突变型IL-13中单个残基处的序参数和雷克斯值。比较突变型IL-13与野生型IL-13的序参量和氨基酸残基处的雷克斯值,发现二者在D-螺旋IL-13处存在差异。突变分析表明IL-13的D-螺旋与IL-13受体α 2相互作用。因此,这表明突变体IL-13与白细胞介素13受体-α的亲和力比野生型IL-13的亲和力弱,这可能取决于IL-13中D-螺旋的内部运动的差异。少

项目成果

期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Obita et al.: "Determination of the secondary structure in solution of the Escherichia coli DnaA DNA-binding domain"Biochem.Biophys.Res.Commun.. 299・1. 42-48 (2002)
Obita等:“大肠杆菌DnaA DNA结合域的溶液中的二级结构的测定”Biochem.Biophys.Res.Commun. 299·1(2002)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Obita et al.: "Solution structure and activity of mouse lysozyme"Cell.Mol.Life Sci.. 60(1). 176-183 (2003)
Obita等人:“小鼠溶菌酶的溶液结构和活性”Cell.Mol.Life Sci..60(1)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
A small chimerically bifunctional monomeric protein:: Tapes japonica lysozyme
  • DOI:
    10.1007/s00018-003-3082-z
  • 发表时间:
    2003-09-01
  • 期刊:
  • 影响因子:
    8
  • 作者:
    Takeshita, K;Hashimoto, Y;Imoto, T
  • 通讯作者:
    Imoto, T
Ohmura et al.: "Fluctuations in free or substrate-complexed lysozyme and a mutant of it detected on x-ray crystallography and comparison with those detected on NMR"J.Biochem.. 131・5. 701-704 (2002)
Ohmura等人:“通过X射线晶体学检测到的游离或底物复合溶菌酶及其突变体的波动以及与通过NMR检测到的结果的比较”J.Biochem.. 131・5(2002)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Identification of the region in Escherichia coli DnaA protein required for specific recognition of the DnaA box.
鉴定大肠杆菌 DnaA 蛋白中特异性识别 DnaA 盒所需的区域。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yoshida et al.
  • 通讯作者:
    Yoshida et al.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

UEDA Tadashi其他文献

UEDA Tadashi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('UEDA Tadashi', 18)}}的其他基金

Establishment of research foundation on "objective pain assessment" using animal models suffering from neuropathic pain
建立使用神经病理性疼痛动物模型进行“客观疼痛评估”的研究基础
  • 批准号:
    26293129
  • 财政年份:
    2014
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of Fab molecule with the stable scaffold for next generation
开发具有下一代稳定支架的 Fab 分子
  • 批准号:
    23655160
  • 财政年份:
    2011
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Study on the development of molecules for depressing neuropathic pain based on tertiary structure of human P2X4 receptor
基于人P2X4受体三级结构的抑制神经性疼痛分子的开发研究
  • 批准号:
    23390155
  • 财政年份:
    2011
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Improved function of ketoamine oxidase for clinical examination reagent of diabetes by use of multiple approaches
多途径提高糖尿病临床检验试剂酮胺氧化酶的功能
  • 批准号:
    20590579
  • 财政年份:
    2008
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
AnaIysis of dynamic behavior of ribonuclease upon ligand binding using high resolution NMR
使用高分辨率 NMR 分析配体结合时核糖核酸酶的动态行为
  • 批准号:
    12672088
  • 财政年份:
    2000
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Construction of an effective renaturation method of denatured proteins based on a biological function
基于生物学功能的变性蛋白有效复性方法的构建
  • 批准号:
    08558072
  • 财政年份:
    1996
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Analysis of dynamic behavior of mutant hen lysozyme with larger catalytic constant using high resolution NMR
利用高分辨率核磁共振分析具有较大催化常数的突变母鸡溶菌酶的动态行为
  • 批准号:
    07680725
  • 财政年份:
    1995
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Interleukin-13 in Central Regulation of Metabolism
Interleukin-13 在代谢中枢调节中的作用
  • 批准号:
    10669632
  • 财政年份:
    2021
  • 资助金额:
    $ 2.24万
  • 项目类别:
Interleukin-13 in Central Regulation of Metabolism
Interleukin-13 在代谢中枢调节中的作用
  • 批准号:
    10313463
  • 财政年份:
    2021
  • 资助金额:
    $ 2.24万
  • 项目类别:
Interleukin-13 in Central Regulation of Metabolism
Interleukin-13 在代谢中枢调节中的作用
  • 批准号:
    10468658
  • 财政年份:
    2021
  • 资助金额:
    $ 2.24万
  • 项目类别:
Molecular Pathways of Interleukin-13 in Cutaneous T-cell Lymphoma
皮肤 T 细胞淋巴瘤中 IL-13 的分子通路
  • 批准号:
    9178480
  • 财政年份:
    2016
  • 资助金额:
    $ 2.24万
  • 项目类别:
Interleukin-13-mediated mechanisms of pulmonary vascular remodeling
白细胞介素13介导的肺血管重塑机制
  • 批准号:
    8996962
  • 财政年份:
    2014
  • 资助金额:
    $ 2.24万
  • 项目类别:
Mechanisms of Interleukin-13 and B1 cells upon prognosis of acute infectious diseases
Interleukin-13和B1细胞对急性传染病预后的影响机制
  • 批准号:
    22591103
  • 财政年份:
    2010
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
INTERLEUKIN-13, ACCUMMULATION OF EXTRAVASCULAR FIBRIN AND AIRWAY CLOSURE
INTERLEUKIN-13,血管外纤维蛋白的积累和气道关闭
  • 批准号:
    7959622
  • 财政年份:
    2009
  • 资助金额:
    $ 2.24万
  • 项目类别:
A novel splice variant of interleukin-13 and its role in promoting EAE responses
IL-13 的新型剪接变体及其在促进 EAE 反应中的作用
  • 批准号:
    7660224
  • 财政年份:
    2009
  • 资助金额:
    $ 2.24万
  • 项目类别:
A novel splice variant of interleukin-13 and its role in promoting EAE responses
IL-13 的新型剪接变体及其在促进 EAE 反应中的作用
  • 批准号:
    7876857
  • 财政年份:
    2009
  • 资助金额:
    $ 2.24万
  • 项目类别:
INTERLEUKIN-13, ACCUMMULATION OF EXTRAVASCULAR FIBRIN AND AIRWAY CLOSURE
INTERLEUKIN-13,血管外纤维蛋白的积累和气道关闭
  • 批准号:
    7720876
  • 财政年份:
    2008
  • 资助金额:
    $ 2.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了